A randomized clinical trial of unfractioned heparin for treatment of sepsis (the HETRASE study): design and rationale [NCT00100308]

ABSTRACT: Introduction: Infection promotes coagulation via a large number of molecular and cellular mechanisms, and this procoagulant activity has boosted basic and clinical research using anticoagulant molecules as therapeutic tools in sepsis. Heparin, which is a naturally occurring proteoglycan th...

Full description

Autores:

Jaimes Barragán, Fabián Alberto
de la Rosa Echavez, Gisela del Carmen
Arango Toro, Clara María
Fortich, Fernando
Morales Uribe, Carlos Hernando
Aguirre Acevedo, Daniel Camilo
Patiño Grajales, Pablo Javier

Tipo de recurso:

Article of journal

Fecha de publicación:

2006

Institución:

Universidad de Antioquia

Repositorio:

Repositorio UdeA

Idioma:

eng

OAI Identifier:

oai:bibliotecadigital.udea.edu.co:10495/36751

Acceso en línea:

https://hdl.handle.net/10495/36751

Palabra clave:

Sepsis
Heparina
Heparin
Coagulación
Coagulation
Insuficiencia Multiorgánica
Multiple Organ Failure
Estudios Longitudinales
Longitudinal Studies
Ensayo Clínico
Clinical Trial

Rights

openAccess

License

http://creativecommons.org/licenses/by/2.5/co/